Etanercept improves psoriatic arthritis patient-reported outcomes : Results from EDUCATE

Etanercept improves psoriatic arthritis patient-reported outcomes : Results from EDUCATE

Experience Diagnosing, Understanding Care, and Treatment With Etanercept (EDUCATE) is a multicenter, phase 4, 24-week, open-label study of the safety and efficacy of etanercept therapy in patients with psoriatic arthritis (PsA) in routine dermatologic practice. We present data on patient-reported ou...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cutis (New York, N.Y.) N.Y.), 2007-04, Vol.79 (4), p.322-326
Hauptverfasser: FRANKEL, Ellen H, STROBER, Bruce E, CROWLEY, Jeffrey J, FIVENSON, David P, WOOLLEY, J. Michael, YU, Elaine B, XIA, Hong A, CHIOU, Chiun-Fang, STEVENS, Seth R
Format: Artikel
Sprache:eng
Schlagworte:
Arthritis, Psoriatic - drug therapy
Biological and medical sciences
Dermatology
Diseases of the osteoarticular system
Etanercept
Female
Health Status
Humans
Immunoglobulin G - therapeutic use
Immunologic Factors - therapeutic use
Inflammatory joint diseases
Male
Medical sciences
Middle Aged
Psoriasis. Parapsoriasis. Lichen
Quality of Life
Randomized Controlled Trials as Topic
Receptors, Tumor Necrosis Factor - therapeutic use
Recombinant Fusion Proteins - therapeutic use
Treatment Outcome
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Experience Diagnosing, Understanding Care, and Treatment With Etanercept (EDUCATE) is a multicenter, phase 4, 24-week, open-label study of the safety and efficacy of etanercept therapy in patients with psoriatic arthritis (PsA) in routine dermatologic practice. We present data on patient-reported outcomes (PROs) from EDUCATE, which demonstrate that subjects with PsA achieved clinically meaningful improvements in both skin- and joint-related PROs after 24 weeks of treatment.
ISSN:0011-4162
2326-6929